Παραπομπή σε μορφή APA (7η εκδ.)

Eustace, A., Mani, N., Span, P., Irlam, J., Taylor, J., Betts, G., . . . West, C. (2013). A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.

Παραπομπή σε μορφή MLA (9th εκδ.)

Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.